ID27208A - Proses untuk alkilasi sulfonamida-sulfonamida yang terhalang yang berguna dalam produksi penghambat-penghambat metaloproteinase matriks - Google Patents

Proses untuk alkilasi sulfonamida-sulfonamida yang terhalang yang berguna dalam produksi penghambat-penghambat metaloproteinase matriks

Info

Publication number: ID27208A
Authority: ID; Indonesia
Prior art keywords: matriers; metaloproteinase; allegation; understanded; sulfonamides
Prior art date: 1998-04-10

Application number

IDW20002031A

Other languages

English (en)

Inventor

Brian M Andresen

Philip D Hammen

Joel M Hawkins

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-10

Filing date

1999-04-09

Publication date

2001-03-08

1999-04-09 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2001-03-08 Publication of ID27208A publication Critical patent/ID27208A/id

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Psychology (AREA)
Psychiatry (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Hospice & Palliative Care (AREA)
Pulmonology (AREA)
Tropical Medicine & Parasitology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
AIDS & HIV (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)

IDW20002031A 1998-04-10 1999-04-09 Proses untuk alkilasi sulfonamida-sulfonamida yang terhalang yang berguna dalam produksi penghambat-penghambat metaloproteinase matriks ID27208A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US8131098P	1998-04-10	1998-04-10

Publications (1)

Publication Number	Publication Date
ID27208A true ID27208A (id)	2001-03-08

Family

ID=22163376

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IDP990304D ID23244A (id)	1998-04-10	1999-04-05	Proses alkilasi sulfonamida terhalang
IDW20002031A ID27208A (id)	1998-04-10	1999-04-09	Proses untuk alkilasi sulfonamida-sulfonamida yang terhalang yang berguna dalam produksi penghambat-penghambat metaloproteinase matriks

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
IDP990304D ID23244A (id)	1998-04-10	1999-04-05	Proses alkilasi sulfonamida terhalang

Country Status (47)

Country	Link
US (2)	US6229025B1 (id)
EP (2)	EP0949245B1 (id)
JP (2)	JP3479511B2 (id)
KR (2)	KR100357660B1 (id)
CN (3)	CN1234396A (id)
AP (1)	AP1095A (id)
AR (1)	AR017731A1 (id)
AT (2)	ATE206392T1 (id)
AU (2)	AU755004B2 (id)
BG (1)	BG63665B1 (id)
BR (2)	BR9910110A (id)
CA (2)	CA2268684C (id)
CO (1)	CO4810299A1 (id)
DE (2)	DE69900321T2 (id)
DK (1)	DK0949245T3 (id)
DZ (1)	DZ2754A1 (id)
EA (1)	EA002277B1 (id)
EG (1)	EG21985A (id)
ES (2)	ES2163316T3 (id)
GT (1)	GT199900047A (id)
HN (1)	HN1999000043A (id)
HR (1)	HRP990106B1 (id)
HU (2)	HUP9901043A1 (id)
ID (2)	ID23244A (id)
IL (2)	IL129168A (id)
IN (1)	IN192485B (id)
IS (1)	IS5018A (id)
MA (1)	MA24833A1 (id)
NO (1)	NO991675L (id)
NZ (1)	NZ335105A (id)
OA (1)	OA11030A (id)
PA (1)	PA8469601A1 (id)
PE (1)	PE20000417A1 (id)
PL (2)	PL343530A1 (id)
PT (1)	PT949245E (id)
RU (1)	RU2197479C2 (id)
SA (1)	SA99200089A (id)
SG (1)	SG75167A1 (id)
SK (1)	SK45399A3 (id)
TN (1)	TNSN99054A1 (id)
TR (2)	TR199900756A2 (id)
TW (1)	TW520354B (id)
UA (1)	UA57039C2 (id)
UY (1)	UY25469A1 (id)
WO (1)	WO1999052862A1 (id)
YU (1)	YU18399A (id)
ZA (2)	ZA992627B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6458822B2 (en)	2000-03-13	2002-10-01	Pfizer Inc.	2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
EP1134207A1 (en) *	2000-03-15	2001-09-19	Pfizer Products Inc.	Process for preparing resorcinol derivatives
EP1208092B1 (en) *	2000-04-07	2006-06-21	Samsung Electronics Co., Ltd.	Sulfonamide derivative as a matrix metalloproteinase inhibitor
US20020073441A1 (en)	2000-12-13	2002-06-13	Ross Brian D.	Compositions and methods for detecting proteolytic activity
US6844373B2 (en) *	2002-05-28	2005-01-18	Alcatel	Composition comprising fluorinated, radiation-curable dyes for surface energy control
US20040225077A1 (en)	2002-12-30	2004-11-11	Angiotech International Ag	Drug delivery from rapid gelling polymer composition
ITFI20040174A1 (it) *	2004-08-03	2004-11-03	Protera S R L	Derivati arilsolfonammidici dell'acido idrossammico ad azione inibitoria di metalloproteinasi
ITBO20050005U1 (it) *	2005-01-31	2006-08-01	Ali Spa	Distributore di bevande ghiacciate e simili

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU523636A3 (ru) *	1973-06-18	1976-07-30	Стауффер Кемикал Компани (Фирма)	Способ получени сульфоксидных или сульфоновых производных тиокарбаматов
ZA794723B (en)	1978-09-11	1980-08-27	Univ Miami	Anti-hypertensive agents
GB9000725D0 (en)	1990-01-12	1990-03-14	Pfizer Ltd	Therapeutic agents
US5506242A (en)	1993-01-06	1996-04-09	Ciba-Geigy Corporation	Arylsufonamido-substituted hydroxamic acids
US5863949A (en) *	1995-03-08	1999-01-26	Pfizer Inc	Arylsulfonylamino hydroxamic acid derivatives
PL331895A1 (en) *	1996-08-23	1999-08-16	Pfizer	Arylosulphonylamino derivatives of hydroxamic acid
AU721748B2 (en)	1997-02-03	2000-07-13	Pfizer Products Inc.	Arylsulfonylamino hydroxamic acid derivatives
ID23668A (id)	1997-08-08	2000-05-11	Pfizer Prod Inc	Turunan asam ariloksiarilsulfonilamino hidroksamat
ES2176913T3 (es)	1997-08-08	2002-12-01	Pfizer Prod Inc	Derivados de acidos arilsulfonilaminohidroxamicos.
PA8469401A1 (es)	1998-04-10	2000-05-24	Pfizer Prod Inc	Derivados biciclicos del acido hidroxamico

1999
- 1999-03-24 PA PA19998469601A patent/PA8469601A1/es unknown
- 1999-03-25 EP EP99302287A patent/EP0949245B1/en not_active Expired - Lifetime
- 1999-03-25 DE DE69900321T patent/DE69900321T2/de not_active Expired - Fee Related
- 1999-03-25 GT GT199900047A patent/GT199900047A/es unknown
- 1999-03-25 IL IL12916899A patent/IL129168A/xx not_active IP Right Cessation
- 1999-03-25 DK DK99302287T patent/DK0949245T3/da active
- 1999-03-25 AT AT99302287T patent/ATE206392T1/de not_active IP Right Cessation
- 1999-03-25 ES ES99302287T patent/ES2163316T3/es not_active Expired - Lifetime
- 1999-03-25 PT PT99302287T patent/PT949245E/pt unknown
- 1999-04-01 OA OA9900073A patent/OA11030A/en unknown
- 1999-04-05 ID IDP990304D patent/ID23244A/id unknown
- 1999-04-06 PE PE1999000277A patent/PE20000417A1/es not_active Application Discontinuation
- 1999-04-06 IS IS5018A patent/IS5018A/is unknown
- 1999-04-07 TN TNTNSN99054A patent/TNSN99054A1/fr unknown
- 1999-04-07 SK SK453-99A patent/SK45399A3/sk unknown
- 1999-04-07 TW TW088105541A patent/TW520354B/zh not_active IP Right Cessation
- 1999-04-07 IN IN522DE1999 patent/IN192485B/en unknown
- 1999-04-07 DZ DZ990055A patent/DZ2754A1/xx active
- 1999-04-07 KR KR1019990011957A patent/KR100357660B1/ko not_active Expired - Fee Related
- 1999-04-07 MA MA25530A patent/MA24833A1/fr unknown
- 1999-04-08 TR TR1999/00756A patent/TR199900756A2/xx unknown
- 1999-04-08 AP APAP/P/1999/001506A patent/AP1095A/en active
- 1999-04-08 EG EG37499A patent/EG21985A/xx active
- 1999-04-08 YU YU18399A patent/YU18399A/sh unknown
- 1999-04-08 AR ARP990101601A patent/AR017731A1/es active IP Right Grant
- 1999-04-08 SG SG1999001651A patent/SG75167A1/en unknown
- 1999-04-08 CA CA002268684A patent/CA2268684C/en not_active Expired - Fee Related
- 1999-04-09 TR TR2000/02950T patent/TR200002950T2/xx unknown
- 1999-04-09 CA CA002327498A patent/CA2327498C/en not_active Expired - Fee Related
- 1999-04-09 ID IDW20002031A patent/ID27208A/id unknown
- 1999-04-09 PL PL99343530A patent/PL343530A1/xx unknown
- 1999-04-09 AU AU23691/99A patent/AU755004B2/en not_active Ceased
- 1999-04-09 PL PL99332451A patent/PL332451A1/xx unknown
- 1999-04-09 HR HR990106A patent/HRP990106B1/xx not_active IP Right Cessation
- 1999-04-09 HU HU9901043A patent/HUP9901043A1/hu unknown
- 1999-04-09 AU AU35527/99A patent/AU760213B2/en not_active Ceased
- 1999-04-09 US US09/290,022 patent/US6229025B1/en not_active Expired - Fee Related
- 1999-04-09 BR BR9910110-6A patent/BR9910110A/pt not_active IP Right Cessation
- 1999-04-09 DE DE69922638T patent/DE69922638T2/de not_active Expired - Fee Related
- 1999-04-09 WO PCT/US1999/007858 patent/WO1999052862A1/en not_active Ceased
- 1999-04-09 NO NO991675A patent/NO991675L/no not_active Application Discontinuation
- 1999-04-09 CN CN99104932A patent/CN1234396A/zh active Pending
- 1999-04-09 UA UA99042034A patent/UA57039C2/uk unknown
- 1999-04-09 JP JP2000543425A patent/JP3479511B2/ja not_active Expired - Fee Related
- 1999-04-09 HU HU0101465A patent/HUP0101465A3/hu unknown
- 1999-04-09 AT AT99917394T patent/ATE284864T1/de not_active IP Right Cessation
- 1999-04-09 HN HN1999000043A patent/HN1999000043A/es unknown
- 1999-04-09 BR BR9902219-2A patent/BR9902219A/pt not_active IP Right Cessation
- 1999-04-09 EA EA199900277A patent/EA002277B1/ru not_active IP Right Cessation
- 1999-04-09 EP EP99917394A patent/EP1068180B1/en not_active Expired - Lifetime
- 1999-04-09 ZA ZA9902627A patent/ZA992627B/xx unknown
- 1999-04-09 CN CN99804961A patent/CN1296474A/zh active Pending
- 1999-04-09 ES ES99917394T patent/ES2234253T3/es not_active Expired - Lifetime
- 1999-04-09 RU RU2000125555/04A patent/RU2197479C2/ru not_active IP Right Cessation
- 1999-04-09 IL IL13877899A patent/IL138778A0/xx unknown
- 1999-04-09 US US09/289,454 patent/US6114568A/en not_active Expired - Fee Related
- 1999-04-09 NZ NZ335105A patent/NZ335105A/xx unknown
- 1999-04-09 KR KR10-2000-7011232A patent/KR100377718B1/ko not_active Expired - Fee Related
- 1999-04-09 BG BG103320A patent/BG63665B1/bg unknown
- 1999-04-12 JP JP10387399A patent/JP3540959B2/ja not_active Expired - Fee Related
- 1999-04-12 CO CO99021411A patent/CO4810299A1/es unknown
- 1999-04-12 UY UY25469A patent/UY25469A1/es unknown
- 1999-05-05 SA SA99200089A patent/SA99200089A/ar unknown
2000
- 2000-08-25 CN CN00126476A patent/CN1288885A/zh active Pending
- 2000-10-02 ZA ZA200005370A patent/ZA200005370B/en unknown

Also Published As

Publication number	Publication date
UA57039C2 (uk)	2003-06-16
ATE206392T1 (de)	2001-10-15
ZA992627B (en)	2000-10-09
UY25469A1 (es)	1999-11-17
ATE284864T1 (de)	2005-01-15
BR9902219A (pt)	2000-04-11
HRP990106B1 (en)	2003-08-31
EP1068180B1 (en)	2004-12-15
TNSN99054A1 (fr)	2005-11-10
AU3552799A (en)	1999-11-01
CO4810299A1 (es)	1999-06-30
AU755004B2 (en)	2002-11-28
JP2002511447A (ja)	2002-04-16
IL129168A0 (en)	2000-02-17
CA2327498A1 (en)	1999-10-21
US6114568A (en)	2000-09-05
BG103320A (en)	2001-08-31
AU760213B2 (en)	2003-05-08
CN1296474A (zh)	2001-05-23
YU18399A (sh)	2002-11-15
NZ335105A (en)	2000-03-27
PT949245E (pt)	2002-02-28
DE69922638T2 (de)	2005-05-19
US6229025B1 (en)	2001-05-08
AU2369199A (en)	1999-10-21
EP1068180A1 (en)	2001-01-17
IS5018A (is)	1999-10-11
IL138778A0 (en)	2001-10-31
KR20010042567A (ko)	2001-05-25
HU9901043D0 (en)	1999-06-28
KR100377718B1 (ko)	2003-03-26
RU2197479C2 (ru)	2003-01-27
NO991675L (no)	1999-10-11
ID23244A (id)	2000-03-30
CN1288885A (zh)	2001-03-28
ZA200005370B (en)	2002-01-03
TR200002950T2 (tr)	2000-12-21
KR100357660B1 (ko)	2002-10-25
PL332451A1 (en)	1999-10-11
PA8469601A1 (es)	2000-09-29
DE69922638D1 (de)	2005-01-20
CA2327498C (en)	2006-01-31
MA24833A1 (fr)	1999-12-31
WO1999052862A1 (en)	1999-10-21
DZ2754A1 (fr)	2003-09-15
TR199900756A2 (xx)	1999-11-22
SK45399A3 (en)	2000-08-14
SA99200089A (ar)	2005-12-03
EA199900277A2 (ru)	1999-10-28
HRP990106A2 (en)	1999-12-31
SG75167A1 (en)	2000-09-19
CA2268684C (en)	2004-07-13
IL129168A (en)	2003-07-06
BG63665B1 (bg)	2002-08-30
CA2268684A1 (en)	1999-10-10
HUP0101465A3 (en)	2002-11-28
DE69900321T2 (de)	2002-07-11
DE69900321D1 (de)	2001-11-08
EP0949245A1 (en)	1999-10-13
BR9910110A (pt)	2001-10-09
HUP0101465A2 (hu)	2002-03-28
TW520354B (en)	2003-02-11
IN192485B (id)	2004-04-24
AR017731A1 (es)	2001-09-12
PL343530A1 (en)	2001-08-27
AP9901506A0 (en)	1999-06-30
OA11030A (en)	2002-02-07
NO991675D0 (no)	1999-04-09
EA002277B1 (ru)	2002-02-28
JP3540959B2 (ja)	2004-07-07
PE20000417A1 (es)	2000-05-24
KR19990082986A (ko)	1999-11-25
CN1234396A (zh)	1999-11-10
HUP9901043A1 (hu)	2000-08-28
EP0949245B1 (en)	2001-10-04
HN1999000043A (es)	1999-11-03
ES2234253T3 (es)	2005-06-16
DK0949245T3 (da)	2002-01-28
AP1095A (en)	2002-08-26
JP2000026400A (ja)	2000-01-25
EA199900277A3 (ru)	2000-04-24
GT199900047A (es)	2000-09-15
ES2163316T3 (es)	2002-01-16
JP3479511B2 (ja)	2003-12-15
EG21985A (en)	2002-05-31

Publication	Publication Date	Title
ID24323A (id)	2000-07-13	Proses hidrosianasi yang tertingkatkan
ID27832A (id)	2001-04-26	Proses peningkatan logam-ligand complex yang dikatalisasi
HUP0203875A3 (en)	2005-01-28	Microcapsule and process for production thereof
ID26007A (id)	2000-11-16	Proses karbonilasi
HUP0204335A3 (en)	2005-04-28	Method for production of diaminodiphenylmethanes
AU8968101A (en)	2002-02-05	Electrochemical element and process for its production
ID25642A (id)	2000-10-19	Proses untuk pembuatan poliol-poliol polieter yang kurang berbau
ID23316A (id)	2000-04-05	Proses karbonilasi
ID30503A (id)	2001-12-13	Proses yang diperbaiki untuk pembuatan heksametilenadiamina
DE69916904D1 (de)	2004-06-09	Tonerherstellungsverfahren
ID19754A (id)	1998-07-30	Metode untuk memproduksi formal siklik secara kontinyu
ID23303A (id)	2000-04-05	Proses pemurnian
ID26580A (id)	2001-01-18	Proses untuk memproduksi produk-produk pektin yang difraksionasi
ID27091A (id)	2001-03-01	Proses untuk produksi poliol poliester rantai panjang tanpa ditingkatkan
DE69927893T2 (de)	2006-06-14	Tonerherstellungsverfahren
DE69919810D1 (de)	2004-10-07	Tonerherstellungsverfahren
GB0416516D0 (en)	2004-08-25	Method of transducing es cells
ID29787A (id)	2001-10-11	Proses untuk memproduksi cairan kaya-metana
PT1326836E (pt)	2004-07-30	Processo de producao de 3-amido-2-cloro-4-metilpiridina
IL154803A0 (en)	2003-10-31	New process for the production of oxabispidines
ID22222A (id)	1999-09-16	Proses pembuatan tiazolidinadiona tersubstitusi
ID24235A (id)	2000-07-13	Proses yang disempurnakan untuk pengambilan kembali hidrogen dalam pembuatan asam tereftalat
ID23244A (id)	2000-03-30	Proses alkilasi sulfonamida terhalang
ID24181A (id)	2000-07-13	Proses kimia
ID21037A (id)	1999-04-08	Proses produksi benda-benda selulosa yang dicetak